OliX Pharmaceuticals, the first Asian company to advance its own proprietary RNA interference (RNAi) technology platform into the clinic, is using RNAi technology to treat skin, eye and lung ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback